Delayed Cancer Surge Among 9/11 Responders Raises Long-Term Health Concerns
Twenty-five years after the September 11 attacks, a third wave of cancers is emerging among responders and survivors, including blood, thyroid, prostate, lung, and digestive system cancers. The World Trade Center Health Program has certified roughly 3,000 members for at least one cancer, and a Northwell Health center reports a 75% increase in lymphoma, thyroid, digestive organ, and prostate cancer cases over the past three years. These delayed malignancies underscore that the health ramifications of toxic exposure continue to unfold.
The WTC Health Program, created by the 2010 James Zadroga Act, currently serves over 140,000 members. While roughly 3,000 enrollees have received certifications for at least one related cancer, participants in the program show better survival outcomes than those not enrolled.
At Northwell Health, clinicians observed a 75% increase in specific cancers—lymphoma, thyroid, digestive organ, and prostate—over a three-year span. This latest wave follows earlier respiratory and psychological conditions, and now also impacts women with breast and gynecological cancers, as well as local residents and students.
This delayed cancer surge could reshape long-term healthcare resource allocation for first responders and survivors. As the third wave emerges decades after exposure, it may necessitate extended monitoring protocols and increased funding for specialized cancer treatments. The improved survival rates among program participants suggest that continued enrollment and early detection could mitigate some future mortality, yet the rising incidence may strain the healthcare system and demand sustained public health vigilance for years to come.